Skip to main content

Theranos, Inc. Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you are an investor in the Series C rounds, or any other form of investing in Theranos, Inc, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

March 16, 2016 (Update) - On January 27, 2016,it was reported that Federal inspectors found deficient practices at a Theranos, Inc. laboratory that pose immediate jeopardy to patient health and safety. On March 8, 2016, it was reported that a federal inspection report said a Theranos, Inc. laboratory ran an important blood test on 81 patients in a six-month period despite erratic res...



You must register (for free) or login to view the entire investigation.